1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Combination Inhalers for Upper Airway Diseases : Products, Markets and Forecasts

Analyzing the Growth of Dual Therapy Inhalers

Combination inhalers – oral inhalers containing two drugs that complement the therapeutic actions of one another – have seen a significant increase in development activity and product proliferation in the past five years. Growth is being driven by improved patient experience as derived from ease-of use (fewer devices/medications to administer) and for many patients improved control of symptoms associated with upper airway diseases. Combination inhalers most commonly consist of an inhaled corticosteroid in combination with a bronchodilator. These products are realizing significant commercial success in the two markets for which they are indicated – Asthma and COPD - both of which are forecast to grow at impressive rates for the remainder of the decade.

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

Report Highlights

- Analyzes the market for combination (dual drug) oral inhalers
- Assesses oral inhalation device technology for delivering multiple drugs, and evaluates product technology issues and evolving market factors
- Provides detailed assessments of combination drug inhalers, their growth prospects and market potential
- Evaluates development-stage dual therapy inhalers and assesses likely market entry timelines
- Provides market data and forecasts for dual drug oral inhaler products to 2022
- Profiles inhaled drug product market participants, their technology, product development activity, and business strategies
- Evaluates the impact of economic, technology, and regulatory factors on inhaled drug companies and their alliance partners

Table Of Contents

Combination Inhalers for Upper Airway Diseases : Products, Markets and Forecasts
Executive Summary
Orally Inhaled Corticosteroid Market Overview
The Upper Respiratory Therapeutics Marketspace
Therapeutic Targets for Combination Inhalers
Competing Drug Treatments
Demand Drivers
Technology Factors
Competitive Landscape
Asthma Market Risks and Opportunities
Global Patient Demographics
Regional Market Drivers
The Growing Therapeutic Need
Inhaler Technologies for Delivering Combination Therapies
Dry Powder Inhalers
DPI Formulation Technology
Characteristics and Parameters
DPI Excipients and Packaging
Metered Dose Inhalers
MDI Device Selection Criteria
Ease-of-Use Factors
Nebulizers
Combination Inhalers - Product Analysis, Market Data and Forecasts
Albuterol/Ipratropium (Nebulizer)
Albuterol/Ipratropium (MDI)
Generic Albuterol/Ipratropium Solution
Fluticasone/Vilanterol (DPI)
Fluticasone/Salmeterol (MDI)
Fluticasone/Salmeterol (DPI)
Budesonide/Formoterol (MDI)
Formoterol/Mometasone (MDI)
Umeclidinium/Vilanterol (DPI)
Development-stage Combination Inhalers
Dry Powder Formulations
Metered Dose Formulations
Nebulized Solutions
Therapeutic Market Assessment
Asthma
Demand Factors
Regional Market Factors
COPD
Demand Factors
Regional Market Factors
Market Factors
Regulatory Issues
Patient Compliance
Prescribing Trends
Healthcare Economics
Regional Market Factors
Connected Devices
Market Sector Company Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Albuterol sulfate Market Research Report 2016

Global Albuterol sulfate Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Albuterol sulfate Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Albuterol sulfate industry, focusing on the main regions ...

Global Fudosteine Market Research Report 2016

Global Fudosteine Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Fudosteine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Fudosteine industry, focusing on the main regions (North America, ...

Global Montelukast Market Research Report 2016

Global Montelukast Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Montelukast Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Montelukast industry, focusing on the main regions (North America, ...


Download Unlimited Documents from Trusted Public Sources

Respiratory Treatment Market in Canada

  • November 2016
    105 pages
  • Respiratory Tre...  

    Dermatological ...  

  • Canada  

View report >

Respiratory Treatment Market in the UK

  • October 2016
    11 pages
  • Respiratory Tre...  

  • United Kingdom  

View report >

Respiratory Treatment Market in India

  • September 2016
    8 pages
  • Respiratory Tre...  

    Cough Cold  

  • India  

View report >

Related Market Segments :

Respiratory Treatment

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.